Do Intensive Hospital Antibiotic Control Programs Prevent the Spread of Antibiotic Resistance?

The relation between antibiotic control and resistance was assessed by review of selected journal articles from 1988 through 1994. Most studies of control or monitoring do not report susceptibility pattern as an outcome measure. Several aspects of bias and confounding prevent more than analysis of temporal association between antibiotic use restriction and resistance pattern. However, in a few institutions there has been an increase in susceptibility to antimicrobials following intensive control or monitoring. Moreover, in a few hospitals, intensive antibiotic control for selected drug-organism pairs was associated with a high prevalence of susceptibility, and the proportion susceptible fell abruptly when control or monitoring was relaxed or removed. These examples, coupled with the recent emergence of new resistant organisms, justify attempts to determine the value of intensive antibiotic control as a preventive practice. Because these studies were performed in single institutions, their power to distinguish associations was poor. Cooperative multicenter studies are needed in which selection and classification biases are addressed prospectively, and in which confounding factors are controlled.

[1]  F. R. Batchelor,et al.  Economic evaluations of antibiotic use and resistance--a perspective: report of Task Force 6. , 1987, Reviews of infectious diseases.

[2]  B. Meyers,et al.  Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program. , 1988, Archives of internal medicine.

[3]  Christine C. Sanders,et al.  β-Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact , 1992 .

[4]  R. Weinstein Resistant bacteria and infection control in the nursing home and hospital. , 1987, Bulletin of the New York Academy of Medicine.

[5]  D. Nafziger,et al.  Attitudes of internal medicine residents regarding influenza vaccination. , 1994 .

[6]  Jerome J. Schentag,et al.  Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. , 1992, Diagnostic microbiology and infectious disease.

[7]  R N Jones,et al.  The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. , 1992, Diagnostic microbiology and infectious disease.

[8]  N.Joel Ehrenkrenz Containing costs of antimicrobial in the hospital: A critical evaluation , 1989 .

[9]  R. Quintiliani,et al.  Strategic antibiotic decision-making at the formulary level. , 1991, Reviews of infectious diseases.

[10]  J. Mcgowan Minimizing Antimicrobial Resistance in Hospital Bacteria: Can Switching or Cycling Drugs Help? , 1986, Infection Control.

[11]  R. Ramphal,et al.  Antibiotic restriction in hospitals associated with medical schools. , 1983, American journal of hospital pharmacy.

[12]  Z. Samra,et al.  An outbreak of multiresistant Klebsiella in a neonatal intensive care unit. , 1993, The Journal of hospital infection.

[13]  W. C. Dunagan,et al.  Formulary control of antimicrobial usage. What price freedom? , 1993, Diagnostic microbiology and infectious disease.

[14]  J. L. Gray,et al.  Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. , 1991, Reviews of infectious diseases.

[15]  Neu Hc Infection problems for the 1990's--do we have an answer? , 1993 .

[16]  J. Warren,et al.  Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. , 1986, Reviews of infectious diseases.

[17]  W. Craig Do Antibiotic Combinations Prevent the Emergence of Resistant Organisms? , 1988, Infection Control & Hospital Epidemiology.

[18]  L. Briceland,et al.  Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. , 1988, Archives of internal medicine.

[19]  P. O'Hanley,et al.  Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital. , 1989, The American journal of medicine.

[20]  R. Quintiliani,et al.  Restriction policies for therapy with combination antibiotics. , 1986, The Journal of infectious diseases.

[21]  R. Ramphal,et al.  Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. , 1990, The Journal of infectious diseases.

[22]  L. Peterson,et al.  Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital , 1991, Antimicrobial Agents and Chemotherapy.

[23]  M. Zervos,et al.  High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. , 1990, Reviews of infectious diseases.

[24]  T. Beam Recent advances in curtailing costs of antimicrobial agents: An update on antimicrobial cost containment programs , 1988 .

[25]  C. Kunin,et al.  Resistance to Antimicrobial DrugsA Worldwide Calamity , 1993, Annals of Internal Medicine.

[26]  T. Frieden,et al.  Inappropriate use of oral ciprofloxacin. , 1990, JAMA.

[27]  L. Saravolatz,et al.  An Outbreak of Gentamicin-Resistant Klebsiella pneumoniae: Analysis of Control Measures , 1984, Infection Control.

[28]  I. Gould Control of antibiotic use in the United Kingdom. , 1988, The Journal of antimicrobial chemotherapy.

[29]  J. Mcgowan Is antimicrobial resistance in hospital microorganisms related to antibiotic use? , 1987, Bulletin of the New York Academy of Medicine.

[30]  F. Koontz Microbial resistance surveillance techniques. Blood culture versus multiple body site monitoring. , 1992, Diagnostic microbiology and infectious disease.

[31]  J. Burke,et al.  Surveillance and control of antibiotic use in the hospital. , 1991, American journal of infection control.

[32]  Mitchell L. Cohen Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.

[33]  D. Goldmann,et al.  Confounding and the Analysis of Multiple Variables in Hospital Epidemiology , 1987, Infection Control.

[34]  S. Barriere Bacterial Resistance to β‐Lactams, and Its Prevention With Combination Antimicrobial Therapy , 1992, Pharmacotherapy.

[35]  J. Marr,et al.  Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. , 1988, The Journal of infectious diseases.

[36]  C. Stratton,et al.  Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. , 1992, Diagnostic microbiology and infectious disease.

[37]  C. Magnussen,et al.  Nosocomial enterococcal infections: association with use of third-generation cephalosporin antibiotics. , 1988, American journal of infection control.

[38]  M. Chren,et al.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. , 1994, JAMA.

[39]  G. Pugliese Lab Errors Responsible for Some False-Positive Multidrug-Resistant TB Cases During Outbreaks , 1994, Infection Control & Hospital Epidemiology.

[40]  C. Stratton,et al.  Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. , 1993, Clinical Therapeutics.

[41]  D. Bamberger,et al.  Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. , 1992, Archives of internal medicine.

[42]  B. Murray New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.

[43]  A. Skolnick New insights into how bacteria develop antibiotic resistance. , 1991, JAMA.

[44]  K S Meyer,et al.  Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins , 1993, Annals of Internal Medicine.